Pulmonary arterial hypertension (PAH) is a severe but treatable form of pre-capillary
pulmonary hypertension caused by pulmonary vascular remodelling. As a result of basic …

This review focuses on Pulmonary Alveolar Microlithiasis (PAM), an autosomal recessive
genetic disorder characterized by calcium crystal deposits (microliths) resulting from loss of …

Purpose Pulmonary arterial hypertension (PAH) is a devastating disease with little effective
treatment. The proliferation of pulmonary artery smooth muscle cells (PASMCs) induced by …

Pulmonary hypertension (PH) is a cardiovascular disorder characterized by substantial
morbidity and mortality rates. It is a chronic condition characterized by intricate pathogenesis …

Abstract miR-135 is a highly conserved miRNA in mammals and includes miR-135a and
miR-135b. Recent studies have shown that miR-135b is a key regulatory factor in cardio …

Pulmonary arterial hypertension (PAH), one subtype of pulmonary hypertension (PH), is a
life-threatening condition characterized by pulmonary arterial remodeling, elevated …

The field of pulmonary hypertension has been transformed beyond recognition over the past
30 years. Advances in the understanding of pathophysiology has led to the testing of …

Chronic obstructive pulmonary disease (COPD) is the most prevalent chronic respiratory
disorder that is becoming the leading cause of morbidity and mortality on a global scale …

Purpose The aim of this study was to evaluate the association between computed
tomography (CT) quantitative pulmonary vessel morphology and lung function, disease …

ABSTRACT Introduction Chronic Obstructive Pulmonary Disease (COPD) and
cardiovascular diseases (CVD) commonly co-exist. Outcomes of people living with both …